Relevant bibliographies by topics / Pharmaceutical marketing. eng

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'Pharmaceutical marketing. eng'

Author: Grafiati
Published: 4 June 2021
Last updated: 12 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmaceutical marketing. eng.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharmaceutical marketing. eng"

1

Smolynets, I. B., B. V. Gutyj, І. І. Khariv, O. Y. Petryshak, and R. I. Lytvyn. "PHARMACEUTICAL MARKETING: OBJECTIVES AND TYPES." Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies 18, no. 2 (August 5, 2016): 151–54. http://dx.doi.org/10.15421/nvlvet6929.

Full text
Abstract:
Pharmaceutical marketing objectives and types depending on demand state are overviewed in this article. Pharmaceutical enterprise has always a certain idea of the desired level of market demand. In practice demand is not always in accordance with level that has been predicted. One can strictly outline eight situations that characterise the state of demand. Every such situation is in accordance with certain marketing managerial task and its types. Conversional marketing is related tomedicines’ negative demand and medical services availability, e.g. such kind of situation, when they cannot find their own buyer at substantial part of potential market. Stimulating marketing is related to demand absence, e.g. state, when potential market does not reveal (or almost does not reveal) interest towards concrete proposal. Marketing that develops is related to medicines demand, that is at the stage of formation (hidden demand). Potential (hidden) demand occurs when certain consumers part need real problem solving, that cannot remain satisfied with the medicines and medical services that are available at the market. Remarketing is related to medicines or medical services decreasing demand situation for a particular period of time, as a result of moral degradation, not consideration sale stimulation tools, advertising updates, and competition factors. Sync marketing (irregular marketing) is related to uneven demand, its fluctuation: seasonality (medicines against a cold,stomach–intestinal diseases and etc.); daily (pharmacies are more often attended during the weekdays, less – at the weekend); hourly (pharmacies are most often attended in a period of time from eight to eleven in the morning and from five to seven in the evening accordingly to research data). Supportive marketing is related to satisfied demand availability. Demarketing is related to surplus of demand, so medicines demand is higher than its supply (producing opportunities). Counteractive marketingis related to irrational (non rational) demand, with harmfulness in terms of health, consumer and society welfare. Market research provisions medicines demand study and projection, price analysis and rivals medicines, market capacity determination and enterprise’s share on it. Such kind of analysis assists to estimate market opportunities and determine attractive marketing activity direction, where enterprise can acquire competitive advantages
APA, Harvard, Vancouver, ISO, and other styles
2

Mohammadzadeh, Mehdi, Nima Bakhtiari, Reza Safarey, and Tayebeh Ghari. "Pharmaceutical industry in export marketing: a closer look at competitiveness." International Journal of Pharmaceutical and Healthcare Marketing 13, no. 3 (September 2, 2019): 331–45. http://dx.doi.org/10.1108/ijphm-02-2018-0011.

Full text
Abstract:
Purpose Competition is tremendously increasing in all business areas, among which the pharmaceutical sector is one of the most profitable fields. Accordingly, an important research effort is to examine whether competitiveness in pharmaceutical markets follows the same rules. The purpose of this paper is to evaluate competitive strategies in this industry and present a proper framework. Design/methodology/approach To this end, a conceptual model of competitive strategies including cost leadership, quality and differentiation was designed based on previously proposed models in the literature. More precisely, the framework was established with the consideration of the pharmaceutical’s specific requirements. For testing the practicality the model, a questionnaire was designed and 80 generic pharmaceutical companies in Iran were selected as the statistical sample and effects of each strategy on export performance was evaluated. The questionnaires were distributed to senior managers and filled through in-person interviews. The collected data were analyzed using binomial, partial least square, confirmatory factor analysis and Friedman tests. Findings Among the strategies under investigation, cost leadership strategy had the strongest effects, while quality ranked second. The proposed framework can also be used for the evaluation of pharmaceutical companies’ export readiness. The results demonstrated that export readiness of the pharmaceutical companies was not desirable. Originality/value The ideas in this paper, which have untold value for pharmaceutical industries, are unique to competitive strategies in export marketing.
APA, Harvard, Vancouver, ISO, and other styles
3

Chhabra, Gurpreet Kaur. "Factors Influencing the Prescription Behaviour of Doctors-An Insight for the Pharmaceutical CRM Strategy Formulation." IRA-International Journal of Management & Social Sciences (ISSN 2455-2267) 15, no. 4 (August 27, 2019): 131. http://dx.doi.org/10.21013/jmss.v15.n4.p6.

Full text
Abstract:
<p>Marketing has always been a major thrust area for the Pharmaceutical industry. Pharma firms usually bear a huge expenditure on marketing, especially sales efforts. Marketing in the Pharmaceutical industry is mainly done through personal selling techniques of promotion through MRs.Marketing of pharmaceutical products to doctors takes place through relationship marketing. Company representatives called medical reps meet the doctors in their specific geographic territory and promote their products to them. The doctors, in turn, prescribe the products to the patients who buy them from the chemist shop. Factors influencing doctor’s prescription behaviour can be classified into three categories: Socio-cultural factors, Personal-Psychological factors, Pharma Marketing factors. Now a day’s companies give a major thrust to the CRM aspect of their marketing strategies. Customer relationship management (CRM) is the strategic process of shaping the interaction between a company and its customers with the goal of maximizing current and lifetime value of customers for the company as well as maximizing, satisfaction for customers.CRM helps Pharma companies to generate revenue from shelf life by reaching more new prescribers (doctors) and patients (end customer) thereby keeping them loyal by increasing their well- being.</p>
APA, Harvard, Vancouver, ISO, and other styles
4

Jablonski, Tomasz. "End of the Transitional Period for Traditional Herbal Medicinal Products Coming Soon." European Journal of Risk Regulation 1, no. 2 (June 2010): 156–59. http://dx.doi.org/10.1017/s1867299x0000026x.

Full text
Abstract:
This section updates readers on the latest developments in pharmaceutical law, giving information on legislation and case law on various matters (such as clinical and pre-clinical trials, drug approval and marketing authorisation, the role of regulatory agencies) and providing analysis on how and to what extent they might affect health and security of the individual as well as in industry.
APA, Harvard, Vancouver, ISO, and other styles
5

Sah, Sunita, and Adriane Fugh-Berman. "Physicians under the Influence: Social Psychology and Industry Marketing Strategies." Journal of Law, Medicine & Ethics 41, no. 3 (2013): 665–72. http://dx.doi.org/10.1111/jlme.12076.

Full text
Abstract:
It is easier to resist at the beginning than at the end.– Leonardo da VinciPhysicians often believe that a conscious commitment to ethical behavior and professionalism will protect them from industry influence. Despite increasing concern over the extent of physician-industry relationships, physicians usually fail to recognize the nature and impact of subconscious and unintentional biases on therapeutic decision-making. Pharmaceutical and medical device companies, however, routinely demonstrate their knowledge of social psychology processes on behavior and apply these principles to their marketing. To illustrate how pharmaceutical marketing strategies use psychological techniques to promote targeted therapies, we draw on the relevant social psychology literature on conflicts of interest and on the six principles of influence articulated by the eminent social psychologist Robert Cialdini. Hospitals, professional organizations, medical educators, and other stakeholders must also draw on social psychology to respond effectively to commercial activities that compromise good medical practice.
APA, Harvard, Vancouver, ISO, and other styles
6

Yousefi, Nazila, Gholamhossein Mehralian, Hamid Reza Rasekh, and Hossein Tayeba. "Pharmaceutical innovation and market share: evidence from a generic market." International Journal of Pharmaceutical and Healthcare Marketing 10, no. 4 (November 7, 2016): 376–89. http://dx.doi.org/10.1108/ijphm-06-2015-0028.

Full text
Abstract:
Purpose Pharmaceutical market value in Iran exceeded to more than US$4bn in 2013, indicating annually over 20 per cent growth. In the past decades, Iranian pharmaceutical industry was supported by government policies, namely, generic substitution, import limitation and local production support; however, the local pharmaceutical manufacturer’s market share in value has been decreased gradually. This study aims to provide historical data on Iran pharmaceutical market to show the importance of new product development to attain greater market share and tries to motivate the pharmaceutical industry located in developing countries to develop more innovative medicines. Design/methodology/approach This is a descriptive cross-sectional study that investigates the Iranian pharmaceutical market by focusing on new products over a five-year period (2009-2014), and that was augmented by an expert panel to rank subjectively firms’ performance indicators to shed light on the importance of new product development to firms’ performance. Findings The expert panel results find out that new product development is one of the most important “result indicators” for Iranian pharmaceutical companies. Historically, in line with the experts’ opinion on the new product development, the Iranian pharmaceutical industry has shown its capability to develop new medicines by developing 3,095 new products (mostly new-to-firm) across about 100 firms. Despite this fact, the share of local manufacturers in new medicines’ market decreased from 52 per cent at the beginning of studied period to 24 per cent at the end, and the gap between the unit value of imported and domestically produced medicines has been significantly increased due to low-innovative medicines locally produced. Research limitations/implications This research was challenged with limitations such as lack of reliable published data on new medicines in the Iran pharmaceutical market. Practical implications This study highlights the fact that developing more innovative products in the generic pharmaceutical industry such as Iran can grant its market share. Originality/value This is an original study that shows the effect of innovative product development on market share through historical data.
APA, Harvard, Vancouver, ISO, and other styles
7

Murzabaeva, Elvira, and Isabek Ismailov. "MARKETING ASSESSMENT OF DRUGS USED FOR TREATMENT OF ACID-RELATED DISEASES IN BISHKEK." Avicenna Bulletin 22, no. 1 (March 1, 2020): 67–73. http://dx.doi.org/10.25005/2074-0581-2020-22-1-67-73.

Full text
Abstract:
Objective: Marketing assessment of anti-ulcer medicines in pharmacies in Bishkek. Methods: The study was used by data from the Department of Medicines and Medical Technology at the Ministry of Health of the Kyrgyz Republic on the registration of pharmaceutical products in the KR – State Registry of Medicines and Medical Products of 2019, as well as price sheets and invoices of wholesale pharmaceutical companies and retail pharmacies in Bishkek. Results: Depending on the value of the turnover rate (TR), the drugs were divided into three groups: drugs with slow TR (0.5 < К < 1.0); drugs with constant TR (0.26 < К < 0.49); drugs with high TR (0 < К < 0.25). According to the results of studies, proton pump inhibitors and colloidal bismuth-based drugs are high-end drugs of TR. Conclusions: We have determined that the pharmaceutical market in Bishkek demonstrates incomplete saturation of anti-ulcer drugs from the total number of registered medicines. At the same time, the largest part of the range are drugs from the group of proton pump inhibitors. Keywords: Anti-ulcer drugs, proton pump inhibitors, marketing assessment, turnover rate.
APA, Harvard, Vancouver, ISO, and other styles
8

Abideen, Ahmed Zainul, and Fazeeda Binti Mohamad. "Supply chain lead time reduction in a pharmaceutical production warehouse – a case study." International Journal of Pharmaceutical and Healthcare Marketing 14, no. 1 (December 9, 2019): 61–88. http://dx.doi.org/10.1108/ijphm-02-2019-0005.

Full text
Abstract:
Purpose The purpose of this study is to apply value stream mapping (VSM) in Malaysian pharmaceutical production warehouse. A current and future state value stream map from the raw material receiving end to the production unit was developed to find out waste and unwanted lead time. It was very much essential to cut down the supply chain lead time at the initial phase as the raw material unloading, sorting, temporary storage and dispatch to production were seen contributing to a huge lead time build-up. Design/methodology/approach The study was initiated with the selection of a product family, construction of the current state map, identification of various wastes and the development of future state map. Findings The expected outcomes of the study include the quantification of wastes, improvement in value-added percentage and lead time reduction. Research limitations/implications The study was carried out in a single pharmaceutical company. The results of the study are deployable and can be functional in similar production organizations. Contrary to common VSMs that capture core production processes, this study provides strong insights that shall help design lean supply chains, especially in the pharmaceutical domain. This paper has also addressed the viability of the lean in the pharmaceutical warehouse and the reduction in lead time to improve demand forecasting, marketing and sales. Practical implications The results of this study have indicated that a significant reduction in pharmaceutical warehouse supply chain lead time is possible as a result of the implementation of VSM from the supply chain’s perspective. Social implications The insights from this study help in understanding the pharmaceutical supply chain risks and their outcomes. Originality/value The paper reports a real-time study conducted in a warehouse of a pharmaceutical organization. Hence, the contributions are original.
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Qing. "R&D/Marketing Interface in a Firm's Capability-Building Process: Evidence from Pharmaceutical Firms." International Journal of Innovation Management 01, no. 01 (March 1997): 23–52. http://dx.doi.org/10.1142/s1363919697000036.

Full text
Abstract:
A considerable number of studies have been assembled over the last decade on the management of the R&D/marketing interface in product innovation. Most of these studies focus on the R&D/marketing interface as a self-contained unit of analysis, offering little explanation of the interface's contribution to a firm's competence building in ways essential to innovation success. This paper is based upon research that demonstrates that the importance of the R&D/marketing interface lies in its dynamic capability in influencing the direction of product development projects towards enhancing existing, or building new, competencies. The case study results show that the shared tasks performed by R&D and marketing departments are concentrated in three areas, i.e. corporate conceptual development (CCD), product conceptual development (PCD) and project implementation (Ip). The results reveal that the performance of the cross-functional team in general, and the R&D/marketing interface in particular, during a project's implementation, is heavily dependent on earlier activities in the areas of CCD and PCD. The former usually involves a sustained period of company-wide strategic preparation, which may or may not be directly targetted at a specific project, whilst the latter refers to previous co-operative experience at the project level. The evidence shows that, even when top management attempts to build an instant platform (e.g. by means of heavyweight project management), in the absence of such earlier activities, the effectiveness of this kind of platform has been far from satisfactory, thus pinpointing the vital importance of learning-before-doing in the innovation process.
APA, Harvard, Vancouver, ISO, and other styles
10

Suraj Kushe Shekhar, Tony P Jose, and Rehin K R. "Consumer buying behavior and attitude towards pharmaceuticals." International Journal of Research in Pharmaceutical Sciences 10, no. 4 (November 2, 2019): 3392–97. http://dx.doi.org/10.26452/ijrps.v10i4.1649.

Full text
Abstract:
Pharmaceutical industry is a fastest growing industry in India. It is valued at above US 40 billion dollars. India exports large amount of drugs to difference parts of the world. Nowadays people are conscious of what they buy. Even if doctors prescribe a medicine, consumers resort to internet to get more information on the medicine before they consume it. Consumers have different perceptions on various kinds of drugs. Understanding the consumer attitude towards drugs will help the marketers to formulate marketing strategies better. The present study examines as to what the consumers look out when they reach to purchase a drug from the pharmacy. This paper scrutinizes and gives insights on consumer behavior and their attitudes towards buying different types of pharmaceuticals (like over-the counter drugs, herbals, ayurvedic, analgesics etc). The paper highlights the importance of factors like price, trust and brand in making importance purchase decisions. Further it was also observed that most of the people prefer buying over-the-counter drugs, which might end up being misused by the consumers. However, it was also found that consumers try to be well-aware of the medicine before buying or consuming it. Along with it, price sensitivity is something which majorly dominates the buying behavior of the consumers.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pharmaceutical marketing. eng"

1

Fiaschetti, Marco Antonio. "Opiniões e atitudes dos médicos frente às ações promocionais da indústria farmacêutica /." Araraquara : [s.n.], 2009. http://hdl.handle.net/11449/96231.

Full text
Abstract:
Resumo: No contexto do uso racional de medicamentos é preciso atentar para as repercussões sociais e econômicas da prescrição médica, visto que esta é influenciada por múltiplos fatores individuais e condicionantes, dentre os quais as ações de marketing farmacêutico. Sabendo-se que a indústria farmacêutica investe maciçamente na promoção de seus produtos e que estudos sugerem que estas ações influenciam a prescrição médica, este trabalho teve por objetivo analisar a vulnerabilidade dos médicos frente aos propagandistas e oferta de cortesias e amostras grátis pelos laboratórios. Para tanto, questionários foram encaminhados aos médicos de Araraquara (SP) contendo perguntas abertas, de identificação, e fechadas sobre o tema. A análise dos dados incluiu estudo de associação em algumas situações de interesse por meio do teste de qui-quadrado. Os resultados indicaram que os médicos se relacionam com os propagandistas (98%) por os considerarem úteis (55%), mas não como fonte principal de atualização (86%), sendo que a maioria (68%) acredita que a qualidade das informações depende do laboratório e não da marca do produto. Para 62% suas prescrições não são influenciadas por tais relacionamentos, principalmente aqueles com maior tempo de formação, enquanto 24% discordam que os médicos em geral são influenciados, assim como os recém-formados (37%). A maioria também discorda que sejam influenciados pelas cortesias (86%) ou pelas amostras grátis (70%), mas apenas 38% acreditam que os colegas não sejam influenciados pelas amostras. Quanto à ética destes recebimentos, 57% concordaram ser apropriado quando beneficiam os pacientes, mas somente 32% quando para uso pessoal. Ao demonstrar relações entre classe médica e propagandistas, os resultados evidenciam que os médicos são vulneráveis às influências do marketing farmacêutico, sendo necessários... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: In the context of rational use of medicines is necessary to look at social and economic repercussions of the prescription as it is influenced by many factors, including the actions of pharmaceutical marketing. Given that the pharmaceutical industry invests heavily in promoting their products and because studies suggest that these actions influence the prescription, this work aims to evaluate the vulnerability of doctors to drug promoters and the offering of gifts and free samples by the laboratories. To this end, questionnaires were sent to doctors of Araraquara (SP) with open and closed questions. Data analysis included study of the association in some situations of interest using the chi-square test. Results indicated that physicians relate to the propagandists (98%) by considering them useful (55%), but not as a main source of update (86%), and the majority (68%) believes that the quality of their information depends on the laboratory and not by the brand of the product. 62% believe that their prescriptions are not influenced by such relationships, especially those with more time for training, but only 24% disagree that doctors in general are influenced, as well as the newly formed (37%). The majority also disagrees that are influenced by courtesies (86%) or the free samples (70%) but only 38% believe their colleagues are not influenced by the samples. Concerning the ethics of these receipts, 57% agreed it appropriate when benefit patients, but only 32% when for personal use. The results demonstrate high level of relationship between physicians and drug promoters, what suggest that they are vulnerable to their influence as well as to the offering of gifts and free samples. Doctors should be cautious about industry influence. Thus restrictive legal mechanisms and other educational interventions are needed to promote the best drug prescription... (Complete abstract click electronic access below)
Orientador: Chung Man Chin
Coorientador: Patrícia de Carvalho Mastroianni
Banca: Chung Man Chin
Banca: Thaís Helena Abrahão T. Queluz
Banca: Rodolpho Telarolli Júnior
Mestre
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pharmaceutical marketing. eng"

1

Jamil, George, Lorena Furbino, Leandro Santos, Marcus Alves, Rafael Santiago, and Silvia Loyola. "A Design Framework for a Market Intelligence System for Healthcare Sector." In Handbook of Research on ICTs and Management Systems for Improving Efficiency in Healthcare and Social Care, 288–305. IGI Global, 2013. http://dx.doi.org/10.4018/978-1-4666-3990-4.ch014.

Full text
Abstract:
The healthcare market is a dynamic sector, where marketing decisions are decisive and critical. Strategic and tactical planning demand data and information to produce knowledge, which will capacitate firms for business maneuvers as product positioning, pricing, and technological implementation for optimal business development. Marketing data and information must be provided from a variety of sources to produce knowledge, in a process that can be characterized as “organizational intelligence.” Collected contents from healthcare associated industrial sectors, such as chemical and pharmaceutical, have the potential to produce integrated value chain knowledge, improving analysis and decision processes. Approaching the healthcare market, a framework for an intelligence system for marketing decisions is discussed in this chapter. Initially reviewing the literature, a conceptual base is formed, which delimits the evaluation of intended framework. As an exam of practical marketing intelligence system application, case studies of real decisions observed in Brazilian market are done at the end of the chapter to evaluate how intelligence and knowledge, as conceptualized in the literature review, serve in typical healthcare marketing competition, as managerial support for problem solutions.
APA, Harvard, Vancouver, ISO, and other styles
2

"The purpose of this is to compensate patentees for the time during which they were not able to exploit their inventions as a result of the need to secure regulatory approval before putting the product onto the market. The regulation came into effect on 2 January 1993 for all then EEC Member States except Spain, Portugal and Greece, for which the regulation will come into effect on 2 January 1998. Typically, 12 years may elapse between discovery or invention and medicinal use, reducing the effective patent term to eight years. This situation has, the Commission says, ‘arisen as a result of the interference between two types of administrative procedure (which) imposes heavy penalties on pharmaceutical research, which is therefore discriminated against as compared with other technological sectors’. Additionally there is provision in the Community for health authorities to grant what is effectively a period of non-patent exclusivity for new drugs. This is done by the health authority agreeing for a given period not to grant approval for any generic drug unless the generic manufacturer submits all of the same test data as the initial applicant. The relevant directive provides that Member States shall provide such exclusivity for a minimum period of six years. As a practical matter, however, most have adopted a term of 10 years. Extensions of patents will be effected by the grant of ‘supplementary protection certificates’ for periods of up to five years after the end of the normal patent term. Subject to this five-year limit, extensions will be for a period of five years less than the delay occurring between the filing of the application giving rise to the patent was granted. The regulation will have retroactive effect to cover some products already on the market. In general such retroactive effect covers drugs that first obtained marketing approval on or after 1 January 1985, although different dates apply for Denmark and Germany (1 January 1988) and Belgium and Italy (1 January 1982). It should be noted that the extension of protection effected by the supplementary certificate is restricted to products that have been granted marketing approval and do not provide for extension of protection for any other subject-matter that might fall within the scope of the patent claims." In Sourcebook on Intellectual Property Law, 295. Routledge-Cavendish, 1997. http://dx.doi.org/10.4324/9781843142928-51.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pharmaceutical marketing. eng"

1

Liberati, Caterina, Elisa Arrigo, and Paolo Mariani. "A Multivariate Approach to Facebook Data for Marketing Communication." In CARMA 2016 - 1st International Conference on Advanced Research Methods and Analytics. Valencia: Universitat Politècnica València, 2016. http://dx.doi.org/10.4995/carma2016.2016.2974.

Full text
Abstract:
The aim of this paper is to propose a method to explore and synthesize social media data in order to aid businesses to make their communication decisions. The research was conducted at the end of 2014 on 5607 Italian Facebook subjects interested in drugs and health. In this study, we refer to the pharmaceutical market that is characterized by strict legal constraints, which prevent any promotional activities (such as advertising) of companies on prescription drugs. Thus, pharmaceutical businesses tend to promote their corporate brand instead of a single product brand. In such context, social media offer the opportunity to gather customers’ information about their attitudes and preferences, helpful to address marketing activities. Through a multivariate statistical approach on Facebook data, we have highlighted the associations existing between TV channels and users’ profiles. Therefore, depending on the value proposition to promote, every business could choose, first, the target group to reach and, then, the nearest suitable channel where to develop the corporate brand communication.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pharmaceutical marketing. eng' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography